The European Medicines Agency’s safety committee has confirmed a “very rare” risk of myocarditis and pericarditis in individuals who’ve had the Pfizer-BioNTech or Moderna Covid vaccines, having conducted large Europe-wide studies.

The data, released following the latest meeting of the European regulator’s Pharmacovigilance Risk Assessment Committee (PRAC), backed up previous concerns about the potential risk posed by the Covid vaccines.

Both myocarditis and pericarditis are deemed “very rare” in recipients of the Comirnaty jab, produced by Pfizer-BioNTech, and Spikevax, previously known as the Moderna vaccine.

Thread Rating:Heart inflammation risk in Pfizer and Moderna jabs evaluated